Skip to content
sellWeak cluster of 4

Madhav Vasanthavada sold $25k of ABEO

Chief Commercial Officer at ABEONA THERAPEUTICS INC.. 4,902 shares at an average of $5.16, traded Sep 29, 2026, filed Sep 29, 2026.

Warning score
35
Value
$25k
4,902 shares
Holdings after
285,721
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $25k at market
    +5
  • Share of holdings sold
    Sold 1.7% of holdings
    0
  • Cluster
    4 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ABEOOct 9, 2026 · close 4.94
Since filing Sep 29, 2026: -4.3%SPY +1.9% · excess -6.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-26-044971, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 29, 2026SOpen-market sale
Common Stock
-4,902$5.16$25k285,72113 d ago

Related signals

Other insiders at ABEONA THERAPEUTICS INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
36Weak
ABEOsell 4
ABEONA THERAPEUTICS INC.
Brendan M. O'Malley
SVP, Chief Legal Officer
$35k
6,727 shares
-2%
43Moderate
ABEOsell 4
ABEONA THERAPEUTICS INC.
Joseph Walter Vazzano
Chief Financial Officer
$47k
9,191 shares
-2%
50Moderate
ABEOsell 4
ABEONA THERAPEUTICS INC.
Vishwas Seshadri
Chief Executive Officer
$101k
19,608 shares
-2%
29Weak
ABEOsell
ABEONA THERAPEUTICS INC.
Mark Alvino
director
$88k
15,000 shares
-19%
15Weak
ABEOsell
ABEONA THERAPEUTICS INC.
Brendan M. O'Malley
SVP, Chief Legal Officer
$3,736
688 shares
-0%
40Moderate
ABEOsell 2
ABEONA THERAPEUTICS INC.
Joseph Walter Vazzano
Chief Financial Officer
$110k
15,000 shares
-3%
34Weak
ABEOsell 2
ABEONA THERAPEUTICS INC.
Eric Crombez
director
$33k
4,718 shares
-10%
37Weak
ABEOsell 7
ABEONA THERAPEUTICS INC.
Joseph Walter Vazzano
Chief Financial Officer
$9,975
1,502 shares
-0%
43Moderate
ABEOsell 7
ABEONA THERAPEUTICS INC.
Mark Alvino
director
$77k
13,093 shares
-14%
40Moderate
ABEOsell 7
ABEONA THERAPEUTICS INC.
Brendan M. O'Malley
SVP, Chief Legal Officer
$102k
17,428 shares
-5%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Madhav Vasanthavada sold $25k of ABEO | InsiderTell